Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

121

dsm-firmenich VenturesLatest Jul 15

Nous · €2.3M Seed P2 Science · $23M Undisclosed

3rounds

0led

Biotech 1Climate tech 1Foodtech 1

Seed 1, Series A 1, Undisclosed 1

Jul 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Undisclosed 1

Nous €2.3M Seed P2 Science $23M Undisclosed Octarine Bio €5M Series A extension

122

T. Rowe Price AssociatesLatest Jul 15

AdvanCell · $315M Series D Third Arc Bio · $52M Series A+

3rounds

—led

Biotech 3

Series C+ 2, Series A 1

Jul 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Series A 1

AdvanCell $315M Series D Third Arc Bio $52M Series A+Parabilis Medicines $305M Series F

123

Marshall WaceLatest Jul 14

Draig Therapeutics · $65M Series B Third Arc Bio · $52M Series A+

3rounds

—led

Biotech 3

Series A 1, Series B 1, Series C+ 1

Jul 14, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 1, Series B 1, Series C+ 1

Draig Therapeutics $65M Series B Third Arc Bio $52M Series A+Parabilis Medicines $305M Series F

124

AstanorLatest Jul 8

Aardaia · €5M Seed Planetary · CHF 22M Series A and credit

3rounds

0led

Foodtech 2Agritech 1

Seed 1, Series A 1, Series B 1

Jul 8, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Series B 1

Aardaia €5M Seed Planetary CHF 22M Series A and credit Standing Ovation €30M Series B

125

S2G InvestmentsLatest Jul 8

Kuehnle AgroSystems · Undisclosed Series B Miraterra Soil · CA$16M Seed

3rounds

—led

Agritech 1Biotech 1Foodtech 1

Seed 1, Series B 1, Undisclosed 1

Jul 8, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series B 1, Undisclosed 1

Kuehnle AgroSystems Undisclosed Series B Miraterra Soil CA$16M Seed Evergreen Select $6M Undisclosed

126

Mubadala CapitalLatest Jun 24

Ollin Biosciences · $330M Series B Alloy Therapeutics · $40M Series E

3rounds

—led

Biotech 3

Series B 2, Series C+ 1

Jun 24, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 2, Series C+ 1

Ollin Biosciences $330M Series B Alloy Therapeutics $40M Series E Juvena Therapeutics $33.5M Series B

127

Cambridge Enterprise VenturesLatest Jun 23

TRIMTECH Therapeutics · $47M Seed+Semarion · $3.8M Undisclosed

3rounds

—led

Biotech 2Climate tech 1

Seed 1, Series A 1, Undisclosed 1

Jun 23, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Undisclosed 1

TRIMTECH Therapeutics $47M Seed+Semarion $3.8M Undisclosed Seprify €13.4M Series A

128

DaphniLatest Jun 22

Graph Therapeutics · $5M Series A Generare · €20M Series A

3rounds

—led

Biotech 3

Series A 2, Seed 1

Jun 22, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Seed 1

Graph Therapeutics $5M Series A Generare €20M Series A baCta €7M Seed

129

DCVC BioLatest Jun 21

Syntax Bio · $14.4M Series A+Latus Bio, Inc. · $97M Series A

3rounds

—led

Biotech 3

Series A 2, Series B 1

Jun 21, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Series B 1

Syntax Bio $14.4M Series A+Latus Bio, Inc. $97M Series A Sidewinder Therapeutics $137M Series B

130

Avego BioScience CapitalLatest May 6

CellCentric · $220M Series D TRex Bio · $50M Undisclosed

3rounds

—led

Biotech 3

Series B 1, Series C+ 1, Undisclosed 1

May 6, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 1, Series C+ 1, Undisclosed 1

CellCentric $220M Series D TRex Bio $50M Undisclosed EpiBiologics $107M Series B

131

Taiho VenturesLatest May 6

Signadori Bio · €11.1M Seed+Crossbow Therapeutics · $77M Series B

3rounds

—led

Biotech 3

Series B 2, Seed 1

May 6, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 2, Seed 1

Signadori Bio €11.1M Seed+Crossbow Therapeutics $77M Series B EpiBiologics $107M Series B

132

Venrock Healthcare Capital PartnersLatest May 6

CellCentric · $220M Series D Korsana Biosciences · $175M Series A

3rounds

—led

Biotech 3

Series A 1, Series B 1, Series C+ 1

May 6, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 1, Series B 1, Series C+ 1

CellCentric $220M Series D Korsana Biosciences $175M Series A Mirador Therapeutics $250M Series B

133

Freeflow VenturesLatest Mar 31

TippingPoint Biosciences · $4.5M Seed Sift Biosciences · $3.7M Pre-Seed

3rounds

—led

Biotech 3

Pre-seed 1, Seed 1, Series A 1

Mar 31, 2026

Details

New companies 3 · Follow-on 0

Stages: Pre-seed 1, Seed 1, Series A 1

TippingPoint Biosciences $4.5M Seed Sift Biosciences $3.7M Pre-Seed Vivere Oncotherapies $10M Series A

134

LocalGlobeLatest Mar 4

Shellworks · $15M Series A baCta · €7M Seed

3rounds

1led

Biotech 2Climate tech 1

Pre-seed 1, Seed 1, Series A 1

Mar 4, 2026

Details

New companies 3 · Follow-on 0

Stages: Pre-seed 1, Seed 1, Series A 1

Shellworks $15M Series A baCta €7M Seed Anzen Industries $2.2M Pre-seed

135

Bristol Myers SquibbLatest Oct 23

Pathos AI · $237M Series E Ratio Therapeutics · $70M Series C

2rounds

1led

Biotech 2

Series C+ 2

Oct 23, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

Pathos AI $237M Series E Ratio Therapeutics $70M Series C

136

ARK InvestLatest Oct 22

Warhound · $200M Seed SonoThera · $125M Series B

2rounds

0led

Biotech 1Defense tech 1

Seed 1, Series B 1

Oct 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series B 1

Warhound $200M Seed SonoThera $125M Series B

137

Builders VCLatest Oct 22

Warhound · $200M Seed The Biological Computing · $25M Seed

2rounds

0led

Defense tech 1Healthtech 1

Seed 2

Oct 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 2

Warhound $200M Seed The Biological Computing $25M Seed

138

Menlo VenturesLatest Oct 22

Warp Sciences · $215M Series A Chai Discovery · $400M Series C

2rounds

0led

Biotech 2

Series A 1, Series C+ 1

Oct 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Warp Sciences $215M Series A Chai Discovery $400M Series C

139

Sequoia CapitalLatest Oct 22

Warhound · $200M Seed Chai Discovery · $400M Series C

2rounds

0led

Biotech 1Defense tech 1

Seed 1, Series C+ 1

Oct 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Warhound $200M Seed Chai Discovery $400M Series C

140

Andera PartnersLatest Oct 19

Nouscom · €120M Series D Exciva · €51M Series B

2rounds

0led

Biotech 2

Series B 1, Series C+ 1

Oct 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Nouscom €120M Series D Exciva €51M Series B

141

CDP Venture CapitalLatest Oct 19

Nouscom · €120M Series D Aptadir Therapeutics · €40M Seed

2rounds

0led

Biotech 2

Seed 1, Series C+ 1

Oct 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Nouscom €120M Series D Aptadir Therapeutics €40M Seed

142

European Investment BankLatest Oct 19

Nouscom · €120M Series D Tensive · ≤€20M Convertible venture debt

2rounds

0led

Biotech 1Healthtech 1

Series C+ 1, Undisclosed 1

Oct 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

Nouscom €120M Series D Tensive ≤€20M Convertible venture debt

143

Xgen VenturesLatest Oct 19

Nouscom · €120M Series D Aptadir Therapeutics · €40M Seed

2rounds

0led

Biotech 2

Seed 1, Series C+ 1

Oct 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Nouscom €120M Series D Aptadir Therapeutics €40M Seed

144

Cambridge Innovation CapitalLatest Oct 16

Microbiotica · £36M Series C first close TRIMTECH Therapeutics · $47M Seed+

2rounds

0led

Biotech 2

Seed 1, Series C+ 1

Oct 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Microbiotica £36M Series C first close TRIMTECH Therapeutics $47M Seed+

145

FlerieLatest Oct 16

Microbiotica · £36M Series C first close AnaCardio · €62.5M Series B

2rounds

0led

Biotech 2

Series B 1, Series C+ 1

Oct 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Microbiotica £36M Series C first close AnaCardio €62.5M Series B

146

Pivotal bioVenture PartnersLatest Oct 16

Estuary Biotherapeutics · $93M Series A Crystalys Therapeutics · $130M Series B

2rounds

0led

Biotech 2

Series A 1, Series B 1

Oct 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Estuary Biotherapeutics $93M Series A Crystalys Therapeutics $130M Series B

147

Seventure PartnersLatest Oct 16

Microbiotica · £36M Series C first close Standing Ovation · €30M Series B

2rounds

0led

Biotech 1Foodtech 1

Series B 1, Series C+ 1

Oct 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Microbiotica £36M Series C first close Standing Ovation €30M Series B

148

TencentLatest Oct 16

Microbiotica · £36M Series C first close Insilico Medicine · $5M Strategic

2rounds

0led

Biotech 2

Series C+ 1, Undisclosed 1

Oct 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

Microbiotica £36M Series C first close Insilico Medicine $5M Strategic

149

TOHO HOLDINGS COLatest Oct 16

AdipoSeeds · Undisclosed Strategic investment Rege Nephro Co · $10.6M Series C

2rounds

0led

Biotech 2

Series C+ 1, Undisclosed 1

Oct 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

AdipoSeeds Undisclosed Strategic investment Rege Nephro Co $10.6M Series C

150

UPMC EnterprisesLatest Oct 16

Estuary Biotherapeutics · $93M Series A ai3Bio · $48M Series A

2rounds

1led

Biotech 2

Series A 2

Oct 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Estuary Biotherapeutics $93M Series A ai3Bio $48M Series A

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.